Key Forces Shaping the Industry
The Rules of Patient Engagement Are Changing Faster than Ever.
Specialty therapies now account for more than half of U.S. drug spend, with over 4,000 advanced therapies in development. As access models evolve and digital adoption lags behind, patients lose touch with the very teams meant to guide their journey.
This exclusive white paper from Momentum Life Sciences reveals what leading pharma brands are doing now to meet these challenges head-on.
You’ll learn:
- How consumer expectations are redefining what “support” means in pharma.
- Where AI in engagement delivers measurable value, and where it doesn’t.
- Why hybrid human + digital models outperform digital-only programs.
- How behavioral science is transforming adherence into empowerment.
- What great looks like in 2026—a checklist for future-ready engagement.
Download the report today!
Offered Free by: Momentum Life Sciences
See All Resources from: Momentum Life Sciences
